FDA Approved: HALOPERIDOL DECANOATE — Supplemental Application (Fresenius Kabi USA, LLC)

View source ↗

Summary

FDA approves a supplemental application for haloperidol decanoate submitted by Fresenius Kabi USA, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Haldol Decanoate (Haloperidol decanoate)

Snippet

SUPPL AP for HALOPERIDOL DECANOATE (HALOPERIDOL DECANOATE)